Valuation dashboard for CAMP4 Therapeutics Corporation (CAMP) with P/E N/A, P/B -362.08, EV/EBITDA -0.12 and dividend yield 0.00%. DCF, Graham Number and Earnings Power Value models plus sector comparison against other Healthcare companies.
CAMP4 Therapeutics Corporation, a biotechnology firm, was established in 2015 by Richard A. Young and Leonard Zon. Based in Cambridge, Massachusetts, its core focus is the identification and development of new therapeutic solutions for patients.
Analysis Summary
CAMP4 Therapeutics Corporation reported revenue of $3.5M in the most recent fiscal year, growing at a 5-year CAGR of -59.2%.
Trailing-twelve-month margins: gross margin 77.8%, operating margin -12.4%, net margin -25.4%.
At the current price of $3.86, CAMP has negative trailing earnings (P/E not meaningful) and an ROE of -314.08%. Market capitalisation stands at $82M.
Balance sheet quality for CAMP: current ratio of 7.4. A debt-to-equity below 1.0 typically signals conservative capital structure, while a current ratio above 1.5 indicates comfortable short-term liquidity.
Valuation Ratios
| Price / Book | -362.08 |
| EV / EBITDA | -0.12 |
| Dividend Yield | 0.00% |
Valuation Models
| DCF Fair Value | $0.36 |
| vs Current Price | -90.7% |
Peer Comparison
| Symbol | Company | Market Cap | P/E | P/B | ROE |
|---|---|---|---|---|---|
| CAMP | CAMP4 Therapeutics Corporation | $82M | -314.1% | ||
| 0QZU.L | Vertex Pharmaceuticals Incorporated | $131.8B | |||
| VRTX | Vertex Pharmaceuticals Incorporated | $130.3B | 29.68 | 6.45 | 23.3% |
| 0R2M.L | Regeneron Pharmaceuticals, Inc. | $84.0B | |||
| REGN | Regeneron Pharmaceuticals, Inc. | $79.8B | 18.79 | 2.57 | 13.8% |
| ARGX | argenx SE | $61.2B | 36.30 | 7.40 | 21.7% |
| MRNA | Moderna, Inc. | $57.8B | 1.34 | -39.2% | |
| RVMD | Revolution Medicines, Inc. | $41.7B | 15.96 | -96.4% |
Price
| Price | $3.86 |
| Market Cap | $82M |
| Exchange | NASDAQ |
| Country | US |
Profitability
| Return on Equity | -314.08% |
| Return on Invested Capital | -69.76% |
| Return on Assets | -114.79% |
| Gross Margin | 77.80% |
| Operating Margin | -1242.50% |
| Net Margin | -2543.74% |
Related companies: ACRV · ALXO · ATYR · BMEA · HYFT · PMVP · QNCX
Explore sector: Healthcare · Biotechnology
More sections of CAMP: Overview · Financials · Statistics · Estimates · Technical · Ownership · News · Events
Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks